|
|
|
Astellas Pharma Inc. and XenoPort, Inc. (NASDAQ:XNPT) today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also...
TOKYO, Nov 17 (Reuters) - Japan's Nikkei stock average is likely to rise on Tuesday after U.S. shares surged due to comments by Federal Reserve Chairman Ben Bernanke that reinforced expectations that interest rates would stay...
SAN MATEO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing...
REDWOOD CITY, Calif. (AP) -- Biotechnology company Maxygen Inc. said Friday it is starting a tender offer to buy back 6.6 million shares of its stock, or about a sixth of its outstanding shares. Maxygen said it will pay between...
SAN FRANCISCO, Nov. 11 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that David Hung, M.D., president and chief executive officer, will present at Lazard Capital Markets Sixth Annual Healthcare conference on...
Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in...
In BW 5972 issued November 6, 2009: First graph, second sentence of release (dated November 6, 2009) should read: The NDA currently under review by the FDA is for the treatment of moderate-to-severe primary Restless Legs...
STAINES, England, November 10 /PRNewswire/ -- Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world's top 20 pharmaceutical companies, can today announce details of an Astellas...
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIVT (telavancin) in the United States. On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved...
.bwcellpaddingleft0 {padding-left: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; margin-top: 0px} .bwtablebottommargin {margin-bottom: 10.0px} .bwtextalignleft {text-align: left} .bwunderlinestyle {text-decoration: ...
